The effect of <it>Lactobacillus brevis</it> KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial

The effect of <it>Lactobacillus brevis</it> KB290 against irritable bowel syndrome: a placebo-controlled double-blind crossover trial

<p>Abstract</p> <p>Background</p> <p>Irritable bowel syndrome (IBS) is a functional disorder of the digestive tract that causes chronic abdominal symptoms. We evaluated the effects of <it>Lactobacillus brevis</it> KB290 (KB290), which has been demonstrated t...

Full description

Bibliographic Details
Main Authors: Murakami Katsumi, Habukawa Chizu, Nobuta Yukihiro, Moriguchi Naohiko, Takemura Tsukasa
Format: Article
Language:English
Published: BMC 2012-08-01
Series:BioPsychoSocial Medicine
Subjects:
Irritable bowel syndrome
<it>Lactobacillus brevis</it> KB290
Probiotic
Online Access:http://www.bpsmedicine.com/content/6/1/16

Similar Items

Similar Items